Genomics, Personalized Medicine and Oral Disease 2015
DOI: 10.1007/978-3-319-17942-1_9
|View full text |Cite
|
Sign up to set email alerts
|

Lichen Planus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 188 publications
0
1
0
Order By: Relevance
“…A unique combination of genomics and proteomics approaches can indeed represent a promising innovation for a unique personalized treatment of OLP and oral cancer [18]. This theoretical premise is unique for its potential clinical value, considering that the marginal (although significant) differences between randomly generated and experimentally validated miRNAs point to the critical importance of prospective validation in a patient cohort [19]. Assuming the prevalence rate reported in reference [2] in the range 1.27-1.57% and a precision of 5%, a minimum number of 20-24 patients, within the 95% confidence interval, is needed to validate our bioinformatics predictions.…”
Section: Discussionmentioning
confidence: 99%
“…A unique combination of genomics and proteomics approaches can indeed represent a promising innovation for a unique personalized treatment of OLP and oral cancer [18]. This theoretical premise is unique for its potential clinical value, considering that the marginal (although significant) differences between randomly generated and experimentally validated miRNAs point to the critical importance of prospective validation in a patient cohort [19]. Assuming the prevalence rate reported in reference [2] in the range 1.27-1.57% and a precision of 5%, a minimum number of 20-24 patients, within the 95% confidence interval, is needed to validate our bioinformatics predictions.…”
Section: Discussionmentioning
confidence: 99%